Author:
Rodolakis Ioannis,Liontos Michalis,Pergialiotis Vasilios,Haidopoulos Dimitrios,Kaparelou Maria,Efthimios Vlachos Dimitrios,Dimopoulos Meletios Athanasios,Loutradis Dimitrios,Rodolakis Alexandros,Bamias Aristotelis,Thomakos Nikolaos
Reference18 articles.
1. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11. Lyon, France: International Agency for Research on Cancer, 2013[2016-09-09]. http://globocan.iarc.fr.
2. Ovarian cancer symptoms, routes to diagnosis and survival - population cohort study in the 'no screen' arm of the UK collaborative trial of ovarian cancer screening (UKCTOCS);Dilley;Gynecol Oncol,2020
3. Symptoms of women with high-risk early-stage ovarian cancer;Chan;Obstet Gynecol,2022
4. ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease;Colombo;Int J Gynecol Cancer,2019
5. Chemotherapy resistance in epithelial ovarian cancer: mechanisms and emerging treatments;Marchetti;Semin Cancer Biol,2021